Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Inovio Pharmaceuticals, Inc. (INO) had Pre-Tax Income of $-6.01M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-6.01M |
|
-- |
|
-- |
|
$18.62M |
|
$-18.62M |
|
$12.61M |
|
|
Pre-Tax Income |
$-6.01M |
$-6.01M |
|
$-6.01M |
|
$-6.01M |
|
$-6.01M |
|
$-6.01M |
|
$-18.62M |
|
$-17.87M |
|
81.62M |
|
81.62M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$39.91M |
|
$1.89M |
|
$9.48M |
|
$49.39M |
|
$39.92M |
|
-- |
|
$5.10M |
|
$45.02M |
|
$4.37M |
|
$4.37M |
|
$4.37M |
|
82.34M |
|
| Cash Flow Statement Financials | |
$-39.64M |
|
$8.78M |
|
$18.11M |
|
$44.27M |
|
$31.53M |
|
$-12.75M |
|
$1.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-39.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-137.55% |
|
-137.55% |
|
-12.17% |
|
-137.55% |
|
$0.05 |
|
$-0.49 |
|
$-0.49 |
|